{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-033520","form_type":"8-K/A","ticker":"ASRT","cik":"0001808665","company_name":"Assertio Holdings, Inc.","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.613415+00:00","generated_at":"2026-06-04T23:13:25.487040+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Assertio files 8-K/A to furnish Q4 2023 earnings call transcript; no new financial data","bullets":["Amendment filed to furnish transcript of March 11, 2024 earnings call; original 8-K delayed due to vendor technical issues.","No changes to previously reported Q4 and full year 2023 financial results; transcript provided as Exhibit 99.2.","Call covered Rolvedon sales growth, generic competition for Indocin, and ongoing CEO search; no specific numbers in this filing.","Forward-looking statements and non-GAAP measures discussed; no updated guidance or material events."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-033520","json":"https://secwatch.observer/filing/0001104659-24-033520.json","markdown":"https://secwatch.observer/filing/0001104659-24-033520.md","text":"https://secwatch.observer/filing/0001104659-24-033520.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924033520/0001104659-24-033520-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924033520/tm248562d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:13:25.487040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e342363decabc514686aee45c536eaafc0ee5321","claim":"Assertio Holdings, Inc. reported financial results for fourth quarter and full year 2023.","evidence_excerpt":"Attached as Exhibit 99.2 hereto, and incorporated by reference herein, is a transcript of the conference call held on March 11, 2024 regarding the Company’s fourth quarter and full year 2023 financial results.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924033520/0001104659-24-033520-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full year 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}